CAMBRIDGE, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders, is scheduled to participate in the C.E. Unterberg, Towbin Emerging Growth Conference on Wednesday, July 11, 2007 at the Mandarin Oriental Hotel in New York City.
